During the past decade, Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine" are "Huntington's Disease" (2 trials), "Mucopolysaccharidosis II" (2 trials), "Huntington Disease" (1 trials), "Huntingtons Disease" (1 trials) and "Stargardt Disease 1" (1 trials). Many other conditions were trialed in "Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine" in a lesser frequency.

Most popular intervention types in "Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "RO7234292 (RG6042)" (2 trials), "No Intervention" (1 trials), "No Study Drug was Administered in this Study" (1 trials) and "RO7234292" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".